Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 70, 2006, Pages 99-103

  Halliday, G M ^a   Del Tredici, K ^b   Braak, H ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE;

BRAIN; CLINICAL FEATURE; COMPARATIVE STUDY; CONFERENCE PAPER; DEMOGRAPHY; DISEASE COURSE; HUMAN; LEWY BODY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL;

EID: 33750349255     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-45295-0_16     Document Type: Conference Paper

References (13)

1. Benarroch EE, Schmeichel AM, Low PA, Boeve BF, Sandroni P, Parisi JE (2005) Involvement of medullary regions controlling sympathetic output in Lewy body disease. Brain 128: 338-344
2. Braak H, Del Tredici K, Rub U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211
3. Braak H, Rüb U, Steur ENH, Del Tredici K, de Vos RAI (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64: 1404-1410
4. Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 125: 2431-2445
5. Jankovic J (2005) Progression of Parkinson's disease. Are we making progress in charting the course? Arch Neurol 62: 351-352
6. Jankovic J, Rajput AH, McDermott MP, Perl DP (2000) The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol 57: 369-372
7. Jellinger KA (2004) Lewy body-related α-synucleinopathy in the aged human brain. J Neural Transm 111: 1219-1235
8. Mikolaenko I, Pletnikova O, Kawas CH, O.Brien R, Resnick SM, Grain B, Troncoso JC (2005) α-Synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Stduy of Aging (BLSA). J Neuropathol Exp Neurol 64: 156-162
9. Parkkinen L, Kauppinen T, Pirttila T, Autere JM, Alafuzoff I (2005) α-Synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 57: 82-91
10. Parkkinen L, Soininen H, Alafuzoff I (2003) Regional distribution of α-synuclein pathology in unimpaired aging and Alzheimer disease. J Neuropathol Exp Neurol 62: 363-367
11. Saito Y, Ruberu NN, Sawabe M, Arai T, Kazama H, Hosoi T, Yamanouchi H, Murayama S (2004) Lewy body-related α-synucleinopathy in aging. J Neuropathol Exp Neurol 63: 742-749
12. Wakisaka Y, Furuta A, Tanizaki Y, Kiyohara Y, Iida M, Iwaki T (2003) Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol 106: 374-382
13. Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL (2005) Risk and protective factors for Parkinson's disease: a study of Swedish twins. Ann Neurol 57: 27-33